Use of percutaneous microwave ablation for the treatment of bone tumors: a retrospective study of clinical outcomes in 47 patients
| Autor: | Jun Lei, Minhao Wu, Lingfei Xiao, Shi-Liang Chen, Feifei Yan, Chong Zhang, Zhouming Deng |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
lcsh:Medical physics. Medical radiology. Nuclear medicine
Adult Male medicine.medical_specialty Percutaneous Visual analogue scale lcsh:R895-920 Bone Neoplasms lcsh:RC254-282 Microwave ablation Quality of life Medicine Humans Radiology Nuclear Medicine and imaging Clinical efficacy Minimally invasive Microwaves Pelvis Bone tumor Radiofrequency Ablation Radiological and Ultrasound Technology business.industry Retrospective cohort study General Medicine Middle Aged lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Sacrum Surgery medicine.anatomical_structure Treatment Outcome Oncology Quality of Life Female business Research Article |
| Zdroj: | Cancer Imaging Cancer Imaging, Vol 19, Iss 1, Pp 1-12 (2019) |
| ISSN: | 1470-7330 1740-5025 |
| Popis: | ObjectiveThe present study aimed to evaluate the short-term clinical performance and safety of percutaneous microwave ablation (MWA) techniques for the treatment of bone tumors.MethodsThis single-institution retrospective study investigated 47 cases of bone tumors treated by MWA from June 2015 to June 2018. The study included 26 patients (55.3%) with benign bone tumors and 21 patients (44.7%) with malignant bone tumors. The tumors were located in the spine or sacrum (15, 31.9%), the upper extremities (6, 12.8%), the lower extremities (17, 36.2%) and the pelvis (9, 19.1%). Outcomes regarding clinical efficacy, including pain relief, quality of life, and intervention-related complications, were evaluated before and after MWA using the visual analog scale (VAS) and the 36-item Short-Form Health Survey (SF-36) scoring system.ResultsOf the 47 patients included in this study, all of them completed follow-up examinations, with a mean follow-up duration of 4.8 ± 1.6 months (range, 2–9 months). Significantly improved VAS and SF-36 scores were recorded after the initial treatment (PConclusionIn our study, the short-term efficacy of MWA was considerably favorable, with a relatively low rate of complications. Our results also showed that MWA was effective for pain relief and improved patients’ quality of life, making it a feasible treatment alternative for bone tumors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink